期刊文献+

肝炎后肝硬化患者实验室检查的临床意义 被引量:1

下载PDF
导出
摘要 目的探讨肝炎后肝硬化患者进行实验室检查的临床意义。方法选取本院2011—2012年收治的肝炎后肝硬化患者56例将其设为观察组,另选取56例正常人将其设为对照组,两组患者分别从胆碱酯酶(CHE)、总胆汁酸(TBA)、谷氨酰转肽酶(GGT)、凝血功能和血小板(PLT)计数等指标进行比较。结果观察组患者血清中GGT、TBA含量增高,与对照组比较差异有统计学意义(P<0.05);观察组患者部分凝血活酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)时间延长,PLT计数减少,与对照组比较差异有统计学意义(P<0.05);观察组患者血清CHE、FIB含量降低,与对照组比较差异有统计学意义(P<0.05)。结论针对肝炎后肝硬化患者进行实验室检查,可有效的评估肝硬化患者的肝脏损害程度以及预后,较为全面的掌握患者疾病的发展趋势,对肝硬化患者的治疗具有较好的指导意义。
机构地区 河北省荣军医院
出处 《临床合理用药杂志》 2014年第12期104-105,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献4

二级参考文献9

共引文献45

同被引文献25

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2Kanauchi O,Fujiyama Y, Mitsuyama K, et al. Increased growth ofBifidobacterium and Eubacterium by germinated barley foodstuff. accompanied by enhanced butyrate production in healthy volunteers [J]. IntJ MolMed, 1999, 3(2): 175-179.
  • 3Johnson-Henry KC, Donato KA, Shen-Tu G, et al. Lactobacil- lus rhamnosus strain GG prevents enterohemorrhagic Escherich- ia coli O157: H7-induced changes in epithelial barrier function [J]. Infect Immunity, 2008, 76(4): 1340-1348.
  • 4Deniel J, O'Sullivan. Genomics ic cultures to improve liver and can advance the potential for probiot- overall health/-J]. Currrent Pharrnae Design, 2008, 14(14) : 1376-1381.
  • 5Clausen MR, Mortensen PB. Lactulose, disaccharides and co Ionic flora, clinical consequences[J]. Drugs, 1997, 53(6) : 930 942.
  • 6Koga H, Tamiya Y, Mitsuyama K, et al. Probiotics promote rapid- turnover protein production by restoring gut flora in patients with al- coholic liver cirrhosis[J]. Hepatol Int, 2013, 7(2): 767-774.
  • 7Arora S, Kaur IP, Chopra K, et al. Efficiency of double layered microencapsulated probiotic to modulate proInflammatory mo- lecular markers for the management of alcoholic liver disease [J]. Mediators of Inflam, 2014, Article ID 715130. 11 pages.
  • 8Nabavi S, Rafraf M, Somi MH, et al. Effects of probiotic yo- gurt consumption on metabolic factors in individuals with nonal- coholic fatty liver disease[J]. J Dairy Sci, 2014, 97(12) : 7386- 7397.
  • 9Shavakhi A, Minakari M, Firouzian H, et al. Effect of a probi- otie and metformin on liver aminotransferases in non-alcoholic steatohepatitis: A double blind randomized clinical trial[J]. Int J Prevent Med, 2013, 4(5): 531-537.
  • 10Bajaj JS, Heuman DM, Hylemon PB, et al. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis[J]. Aliment Pharma- col & Therapeut, 2014, 39(10): 1113-1125.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部